Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,000
Closed -$202K 1741
2025
Q4
$202K Buy
+2,000
New +$217K ﹤0.01% 987
2025
Q3
Sell
-8,309
Closed -$998K 1193
2025
Q2
$998K Buy
8,309
+2,264
+37% +$302K 0.02% 615
2025
Q1
$890K Buy
+6,045
New +$923K 0.03% 554
2024
Q4
Sell
-4,982
Closed -$812K 1781
2024
Q3
$812K Buy
+4,982
New +$738K 0.02% 973
2023
Q4
Sell
-18,491
Closed -$2.42M 1849
2023
Q3
$2.42M Buy
18,491
+14,529
+367% +$2.21M 0.05% 333
2023
Q2
$630K Buy
+3,962
New +$639K 0.01% 723
2021
Q3
Sell
-5,425
Closed -$976K 1315
2021
Q2
$976K Buy
+5,425
New +$990K 0.02% 577
2020
Q1
Sell
-1,340
Closed -$206K 657
2019
Q4
$206K Sell
1,340
-18,393
-93% -$2.75M 0.01% 664
2019
Q3
$3M Buy
19,733
+15,699
+389% +$2.48M 0.18% 112
2019
Q2
$618K Buy
+4,034
New +$616K 0.04% 246

Other funds holding CLX

Centiva Capital's CLX Position: Q1 2026 in Review

Centiva Capital sold out of Clorox (CLX) in Q1 2026, closing a stake of 2,000 shares — an estimated $202K sold.

Centiva Capital first reported a position in CLX in Q2 2019 and held it in 10 quarters. The position peaked at $3M in Q3 2019. 1,086 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Centiva Capital reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 2,000 Clorox shares in Q1 2026, an estimated $202K.
  • Centiva Capital first reported a position in Clorox in Q2 2019 and held it in 10 quarters.
  • Centiva Capital's Clorox position peaked at $3M in Q3 2019.
  • 1,086 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.